The PI3K pathway appears to be critical in the development of CRPC: in vitro data suggest that overexpression and activation of AKT can trigger prostate cancer androgen escape via altered sensitivity and activation of AR (Edwards and Bartlett, 2005). This evidence concerns the gene AKT1 and Familial prostate cancer.